SCHIMMEL PAUL — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

SCHIMMEL PAUL has filed 2 SEC Form 4 filings across 1 company in the last 90 days — buying. Lifetime open-market purchases: $961K.

Profile

Paul Schimmel is a prominent figure in the biopharmaceutical industry, known for his work in drug development and research. He has been associated with aTYR Pharma Inc, where he has contributed to the advancement of therapies for rare diseases. Schimmel has a background in biochemistry and has held various leadership roles in scientific research and corporate governance.

Board memberships

• aTYR Pharma Inc

Awards & honors

• Contributed to drug development for rare diseases
• Leadership roles in biopharmaceutical companies

Recent Transactions

Companies — Last 90 Days

• aTYR PHARMA INC (ATYR) — 2 filings, last 2026-05-28

Frequently Asked Questions

Who is SCHIMMEL PAUL?

Paul Schimmel is a prominent figure in the biopharmaceutical industry, known for his work in drug development and research. He has been associated with aTYR Pharma Inc, where he has contributed to the advancement of therapies for rare diseases. Schimmel has a background in biochemistry and has held various leadership roles in scientific research and corporate governance.…

How many SEC Form 4 filings has SCHIMMEL PAUL submitted recently?

2 primary Form 4 filings in the last 90 days, covering 1 company.

Has SCHIMMEL PAUL been buying or selling stock?

Recorded transactions: 3 open-market purchases ($961K) and 0 open-market sales () across all tracked filings.

Where can I see all of SCHIMMEL PAUL's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week